Muken Ross 4
4 · SOPHiA GENETICS SA · Filed May 20, 2026
Research Summary
AI-generated summary of this filing
SOPHiA GENETICS (SOPH) President Muken Ross Sells 761 Shares
What Happened Muken Ross, President of SOPHiA GENETICS SA (SOPH), sold 761 shares on 2026-05-19 in open-market transactions. The weighted-average price reported was $4.60 per share (range $4.54–$4.66), for a total proceeds of $3,501. The filing indicates these sales were to satisfy tax withholding obligations related to RSUs and were executed under a pre-established Rule 10b5-1(c) plan (not discretionary).
Key Details
- Transaction date: 2026-05-19 (Form 4 filed 2026-05-20). Filing appears timely.
- Transaction type/code: Sale (S); open-market sale to cover tax withholding (F = tax withholding).
- Shares sold: 761; weighted-average price: $4.60; price range: $4.54–$4.66.
- Total proceeds: $3,501.
- Footnotes: F1 — sale to satisfy tax withholding from RSU vesting on 2026-05-18; F2 — weighted average price with per-trade price range, and availability of per-price breakdown on written request.
- Shares owned after transaction: Not specified in this filing.
Context These sales were executed pursuant to a pre-established 10b5-1 trading plan to cover withholding for vested restricted stock units, which is a routine administrative transaction and not an open-market discretionary sell signal. Retail investors should view this as tax-related selling rather than an explicit change in insider sentiment.
Insider Transaction Report
- Sale
Ordinary Shares
[F1][F2]2026-05-19$4.60/sh−761$3,501→ 680,911 total
Footnotes (2)
- [F1]Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on May 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.54 to $4.66, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.